Partner Content Partner Content Topics Presented this February 2018 at RNA Therapeutics RNA Therapeutics 2018
Partner Content Partner Content SMi Group: Exclusive Speaker Interview with Professor Nagy H... RNA Therapeutics
Partner Content Partner Content New Confirmed Delegates & Speakers for RNA Therapeutics RNA Therapeutics
Partner Content Partner Content ProQR Therapeutics: RNA Therapeutics for Patients with Cysti... RNA Therapeutics
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
